Back

Risk factors for heart failure after epirubicin chemotherapy for breast or colorectal cancer

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Comorbodities Cancer/Cardiotoxicity HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Gyorgy Fogarassy

Balatonfured State Cardiology Hospital, Balatonfured (Hungary)

29 More presentations in this session

Presentation thumbnail
Chemotherapy-induced cardiotoxicity in a Colombian heart failure program
Doctor C. Saldarriaga (Medellin, CO)
Abstract Slides
Presentation thumbnail
Cardiovascular monitoring and management in cancer patients: a french national survey
Presentation thumbnail
Subgroups analyses of a prospective long-term study in patients with advanced cancer - the prognostic impact of elevated heart rate.
Doctor M. Anker (Berlin, DE)
Abstract
Presentation thumbnail
The cumulative effect of chemoradiotherapy in the risk of developing cardiotoxicity
Doctor A. Gomes (Almada, PT)
Abstract
Presentation thumbnail
Improving ventricular function in patients with severe ventricular dysfunction previous to kidney transplantation.
Doctor C. Martinez Hernandez (San Luis Potosi, MX)

Access the full session

Session thumbnail
Poster session 3 - Comorbodities

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources